Cosmetic Surgery Market

By Surgery Type;

Liposuction, Eyelid And Nose Surgery, Body Contouring, Facial Reconstruction, Cosmetic Implants, and Others

By Procedure;

Surgical Procedures and Non-Surgical Procedures

By End User;

Ambulatory surgical facility, Hospital & clinic, Office, and Cosmetic Surgical Centre

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn218025663 Published Date: August, 2025 Updated Date: September, 2025

Cosmetic Surgery Market Overview

Cosmetic Surgery Market (USD Million)

Cosmetic Surgery Market was valued at USD 94,162.02 million in the year 2024. The size of this market is expected to increase to USD 205,574.09 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 11.8%.


Cosmetic Surgery Market

*Market size in USD million

CAGR 11.8 %


Study Period2025 - 2031
Base Year2024
CAGR (%)11.8 %
Market Size (2024)USD 94,162.02 Million
Market Size (2031)USD 205,574.09 Million
Market ConcentrationLow
Report Pages335
94,162.02
2024
205,574.09
2031

Major Players

  • Allergan Plc
  • Mentor Worldwide LLC (Johnson & Johnson Services Inc.)
  • Polytech Health & Aesthetics GmbH
  • GC Aesthetics
  • Sientra Inc
  • Hans Biomed Co. Ltd
  • Galderma S.A. (A Nestle Company)
  • Cutera Inc. Anika Therapeutics Inc.)
  • Alma Lasers Ltd. (Shanghai Fosun Pharmaceuticals Ltd.)

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Cosmetic Surgery Market

Fragmented - Highly competitive market without dominant players


The Cosmetic Surgery Market is expanding rapidly as demand for aesthetic improvements continues to rise. More than 65% of individuals now show interest in cosmetic procedures to enhance appearance and self-confidence. With innovations making treatments safer and recovery times shorter, the adoption rate of cosmetic interventions is steadily increasing.

Shift Toward Minimally Invasive Options
Minimally invasive and non-surgical methods account for nearly 70% of cosmetic procedures, reflecting strong consumer preference for safer, faster, and more convenient options. Treatments such as dermal fillers, injectables, and laser therapies are driving this transformation due to their effectiveness and reduced downtime.

Advancements in Technology Driving Precision
Around 60% of practitioners now utilize advanced imaging tools like 3D simulation to enhance planning and precision. The rise of laser-based systems and robotic-assisted methods is making cosmetic surgery more efficient, leading to higher safety levels and better patient satisfaction.

Impact of Social Media on Patient Choices
Digital platforms strongly influence consumer behavior, with 55% of patients reporting that social media shapes their perception of beauty and motivates procedure adoption. Enhanced visibility of results and peer recommendations are key factors increasing interest in cosmetic enhancements.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Surgery Type
    2. Market Snapshot, By Procedure
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Cosmetic Surgery Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Growing beauty consciousness
        2. Technological advancements
        3. Increasing disposable incomes
        4. Influence of social media
        5. Advancements in surgical techniques
      2. Restraints
        1. High costs involved
        2. Health risks associated
        3. Regulatory limitations
        4. Lack of insurance coverage
        5. Stigma attached
      3. Opportunities
        1. Innovations in procedures
        2. Emerging markets growth
        3. Non-invasive techniques
        4. Personalized treatment options
        5. Increasing male clientele
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Cosmetic Surgery Market, By Surgery Type, 2021 - 2031 (USD Million)
      1. Liposuction
      2. Eyelid & Nose Surgery
      3. Body Contouring
      4. Facial Reconstruction
      5. Cosmetic Implants
      6. Others
    2. Cosmetic Surgery Market, By Procedure, 2021 - 2031 (USD Million)

      1. Surgical Procedures

      2. Non-Surgical Procedures

    3. Cosmetic Surgery Market, By End User, 2021 - 2031 (USD Million)
      1. Ambulatory Surgical Facility
      2. Hospital & Clinic
      3. Office
      4. Cosmetic Surgical Center
    4. Cosmetic Surgery Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Latin America

        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
      5. Middle East & Africa

        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
  6. Competitive Landscape
    1. Company Profiles
      1. AbbVie (including Allergan Aesthetics)
      2. Bausch Health Companies (incl. Solta Medical)
      3. Johnson & Johnson (including Mentor Worldwide)
      4. Galderma
      5. Merz Pharma (Merz Aesthetics)
      6. Cynosure
      7. Cutera
      8. Evolus
      9. Lumenis
      10. Alma Lasers
      11. Sientra
      12. Solta Medical (if not already integrated under Bausch Health listing)
      13. Alma Lasers Ltd. (Shanghai Fosun Pharmaceuticals Ltd.)
  7. Analyst Views
  8. Future Outlook of the Market